Detalhe da pesquisa
1.
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis.
Am J Hematol
; 99(4): 774-779, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38343062
2.
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter study.
Am J Hematol
; 98(10): 1588-1597, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470365
3.
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are relapsed or refractory to ruxolitinib: A single-arm, open-label, phase 2, multicenter study.
Am J Hematol
; 98(10): 1579-1587, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37466271
4.
MN1::ETV6-positive de novo T-cell acute lymphoblastic leukaemia is sensitive to venetoclax: A case report.
Br J Haematol
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38685592
5.
Osteolytic lesion as initial presentation in FIP1L1-PDGFRA-rearranged myeloid/lymphoid neoplasm with eosinophilia: a case report.
Ann Hematol
; 103(1): 357-360, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37777636
6.
Improved long-term survival in all Sanz risk patients of newly diagnosed acute promyelocytic leukemia treated with a combination of retinoic acid and arsenic trioxide-based front-line therapy.
Hematol Oncol
; 2018 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29862538
7.
IDH1R132S -mutated acute lymphoblastic leukaemia resembles Burkitt lymphoma/leukaemia via activating MYC.
Br J Haematol
; 192(2): e44-e47, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33222166
8.
Klf10 inhibits IL-12p40 production in macrophage colony-stimulating factor-induced mouse bone marrow-derived macrophages.
Eur J Immunol
; 43(1): 258-69, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23065757
9.
Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy.
Ann Hematol
; 93(6): 941-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24408159
10.
Spred1 deficit promotes treatment resistance and transformation of chronic phase CML.
Leukemia
; 36(2): 492-506, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34564700
11.
Characteristics of chemotherapy-induced diabetes mellitus in acute lymphoblastic leukemia patients.
J Zhejiang Univ Sci B
; 21(9): 740-744, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32893530
12.
Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study.
J Cancer Res Clin Oncol
; 146(2): 357-365, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31938902
13.
miR-221-3p Delivered by BMMSC-Derived Microvesicles Promotes the Development of Acute Myelocytic Leukemia.
Front Bioeng Biotechnol
; 8: 81, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32117949
14.
Expression of hypoxia-inducible factor-1a predicts benefit from rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in diffuse large B-cell lymphoma.
Int J Clin Exp Pathol
; 11(9): 4472-4482, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-31949844
15.
Homoharringtonine targets Smad3 and TGF-ß pathway to inhibit the proliferation of acute myeloid leukemia cells.
Oncotarget
; 8(25): 40318-40326, 2017 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28454099
16.
[Efficacy of HAA regimen in the treatment of 64 patients with refractory/relapsed acute myeloid leukemia].
Zhonghua Xue Ye Xue Za Zhi
; 37(2): 100-4, 2016 Feb.
Artigo
em Zh
| MEDLINE | ID: mdl-27014977
17.
Hypofibrinogenemia as a clue in the presumptive diagnosis of acute promyelocytic leukemia.
Leuk Res
; 50: 11-16, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27631158
18.
Acute myocardial/cerebral infarction as first/relapse manifestation in one acute promyelocytic leukemia patient.
Int J Clin Exp Med
; 8(8): 14210-3, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26550398
19.
Identification and functional analysis of the autofluorescent substance in Limonium bicolor salt glands.
Plant Physiol Biochem
; 97: 20-7, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26397201
20.
Low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus idarubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia.
Leuk Lymphoma
; 56(6): 1691-7, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25257348